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Oligodendrocytes ynthesize. dramatic amounts of myelin membrane. We hypothesized that this requires unique aspects of vesicular trafficking. 
Specifk stages of the oligodendrocyte lineage were assayed for low molecular weight GTP-binding proteins implicated in the regulation of vesicular 
transport pathway (two dimensional gel electrophoresis, [cc-~~P]GTP overlay). Consistent with the hypothesis, as oligodendrocytes differentiate from 
early progenitors to mature myelin-producing cells, 2 12 small GTP-binding proteins become up-regulated. Myelin membrane also has a complex 
pattern of GTP-binding proteins. Several of these proteins may be specific to oligodendrocytes, uggesting that oligodendrocytes may utilize cell-type 
specific GTP-binding proteins for biogenesis and maintenance of the myelin membrane. 
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1. Introduction 
The oligodendrocyte (OL) ensheathes axons in the 
central nervous system with myelin, a cell-specific, multi- 
lamellar membrane continuous with the cell’s plasma 
membrane [ 11. During development oligodendrocytes 
undergo dramatic morphological and biochemical 
changes during a highly regulated course of differentia- 
tion from progenitors to mature oligodendrocytes which 
are capable of myelinating axons. This pathway is exper- 
imentally defined both in vitro and in vivo by stage spe- 
cific antigens [2] (Fig. l), and proceeds accurately in 
culture up to actual myelination even in the absence. of 
neurons [3,4]. Oligodendrocytes grown in defined culture 
conditions can be expanded and developmentally syn- 
chronized through the application of specific growth fac- 
tors (Fig. 1) [1,5-7], allowing for the analysis of develop- 
mental-stage specific cellular events. The manner in 
which an oligodendrocyte prepares for and executes the 
biogenesis of dramatic amounts of myelin membrane in 
a developmentally regulated manner is of specific inter- 
est. 
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growth factor; bFGF, basic fibroblast growth factor; GD3+, cells ex- 
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galactosylcerebroside; OL, oligodendrocytes; MBP, myelin basic 
protein. 
Membrane biogenesis requires a number of molecular 
components for directing vesicular traffic between par- 
ticular intracellular compartments [S-10]. Conserved 
constituents are required to accomplish steps in vectorial 
transport that occur similarly in all cells (e.g. transport 
of vesicles from the endoplasmic reticulum to the cis- 
Golgi); cell type specific constituents allow transport and 
sorting of proteins to specialized membrane domains 
(e.g. transport of proteins and lipids from the rruns-Golgi 
network to the basolateral and apical domains of polar- 
ized epithelial cells [l I]). 
The pathways by which cells target newly synthesized 
proteins from donor to acceptor membranes utilize a 
number of small GTP-binding proteins [12]. The rab 
family is one class of these small GTP-binding proteins 
[13-l 51, and are the mammalian homologues of the yeast 
membrane transport proteins yptlp and Sec4p [16]. A 
number of rab gene products have been identified [ 17, 
primarily through differential cDNA library screening 
and/or RACE-PCR. These 21-25 kDa proteins are -30% 
homologous to the ras gene product, and maintain four 
highly conserved regions in the open reading frame cor- 
responding to either the GTP-binding region or the in- 
trinsic GTPase activity [12,18]. 
Cell type specific rab proteins have been described. 
For example, rab3a is postulated to regulate Ca*‘-de- 
pendent secretion in the synaptic terminal of neurons 
[19], neuroendocrine [20], and also some exocrine and 
endocrine cells [21]; rab3d appears to be localized to 
glucose transporter-containing vesicles in adipocytes 
where it may control insulin-dependant exocytosis [22]; 
rab8 plays a role in membrane traffic from the trans- 
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Golgi network to the basolateral plasma membrane in 
Maden-Darby Canine Kidney (MDCK) cells [23] and 
dendritic processes in hippocampal neurons [24]; and 
rab17 is expressed by epithelial cells localized to the 
basolateral plasma membrane and apical tubules [25]. 
These data indicate that specific membrane trafficking 
programs exist that help achieve terminal differentiation 
by directing the placement of cell-type specific products. 
Here we report the developmentally regulated expres- 
sion of GTP-binding proteins in oligodendrocytes and 
myelin. We present data showing that as oligodendro- 
cytes undergo differentiation from early progenitor cells 
to mature myelin-producing cells, the pattern of expres- 
sion of small GTP-binding proteins, several of which 
may be unique to oligodendrocytes and myelin, becomes 
substantially more complex. These data are interpreted 
in terms of the predicted alterations in molecular cy- 
toarchitecture as oligodendrocytes differentiate into cells 
capable of synthesizing and assembling the vast amounts 
of myelin membrane needed for normal brain develop- 
ment. 
2. Materials and methods 
2.1. Cell culture 
Oligodendrocyte progenitors were collected by overnight shaking 
[26] of mixed primary cultures derived from perinatal rat telencephalon 
[4] grown for 11 days. Purified oligodendrocyte populations at specific 
stages of the lineage were prepared and maintained in a modified 
detined media 141 on 100 mm tissue culture dishes (Falcon) pre-coated 
with poly-omit&e. Progenitor expansion and synchronization of early 
nroaenitors (nositive for eanzlioside GD, (GD,‘)) was achieved bv the 
iim;ltaneouiaddition of-lo&ml of both the-platelet derived growth 
factor (PDGF-BB) (a generous gift of Upstate Biotechnology Institute) 
and basic fibroblast growth factor (bFGF) (Upstate Biotechnology 
Institute) each day for three days [5]. Later progenitor stage cells were 
obtained by releasing GD,+ populations into medium supplemented 
with bFGF in the absence of PDGF for two more days [6,7]. Popula- 
tions of cells in later stages of the lineage (Pre-Galactocerebroside stage 
(Pre-GalC), Immature OL, Mature OL) were obtained by releasing the 
cells after five total days in growth factor into defined medium [4] 
without supplementation with PDGF or bFGF. Pre-GalC stage cells 
were also prepared by antibody perturbation with RmAb [271. Each of 
these blocks is reversible, and upon release the cells resume normal 
lineage progression and enter terminal differentiation. Lineage stages 
were defined by the appearance of specific antigens determined by 
immunofluorescence microscopy ([ 11; see below). 
Astrocytes were isolated from the shaken mixed primary cultures 
used to generate oligodendrocytes as previously described [28], with the 
addition of complement lysis using both monoclonal antibody A2B5 
[29] and RmAb [30,31]. Astrocyte populations were > 99% pure as 
judged by immunoflourescence microscopy with anti-ghal fibrillary 
acidic protein and monoclonal antibody A2B5. 
2.2. Immunojluorescence microscopy and antibodies 
Detection of stage specific antigens has been described previously 
[1,27,31,32] (Fig. 1). The following definitions were used to delineate 
particular stages, using the monoclonal antibodies A2B5, 04, RmAb, 
01, and anti-GD, and polyclonal anti-myelin basic protein (MBP): 
A2B5’04-, GD,+(O-2A) Early Progenitors; A2B5+04’, Late Progeni- 
tors (Pro-oligodendroblasts); 04’RmAb+Ol-, cells at the progenitor- 
oligodendrocyte interface (Pre-GalC); O4RmAb+01’(GalC+). Imma- 
ture Oligodendrocytes (Immature OL); Ol’MBP’, Mature Oligoden- 
drocytes (Mature OL). In this particular study, the phenotypes of the 
analysed populations were as follows: Early Progenitors (97% A2B5’, 
3% 04’, < 1% Ol+); Late Progenitors (> 85% 04’, 4% R-mAb’, 
< 1% 01’): Immature OL (97% 04’. > 85% R-mAb+. 40% 01’): More 
Mature dL (95% 04’, > 85% 01+,‘40% MBP+). 
2.3. Purification of rat brain myelin 
Myelin purification was carried out using a combination of methods 
[33-351 with some additional steps. Rat brain was homogenized in 0.85 
M sucrose (5% w/v), overlayed with 0.32 M sucrose and centrifuged at 
28,000 rpm for 60 min in an SW-28 rotor. The interfaces were homog- 
enized in 100 ml 0.85M sucrose, overlaid with 0.32 M sucrose and 
centrifuged as above. The interfaces were resuspended in200 ml ddHtO 
and centrifuged at 32,008 rpm in a Ti-60 rotor. The pellets were twice 
resuspended in 10 mM EGTA (PH 7.5), homogenized, brought to 200 
ml, stirred for 30 min at 4°C and the suspension was centrifuged at 
10,000 rpm for 15 min. The pellets were homogenized in 0.85 M su- 
crose/2 mM EGTA (PH 7.5), overlayed with 0.32 M sucrose, and 
centrifuged in a SW-28 rotor at 28,000 rpm for 90 min. The interfaces 
were collected, and the sucrose washout repeated. The pellets were 
resuspended in 10 mM EGTA @H 7.5), homogenized, stirred for 15 
min at 4°C and the suspension was pelleted at 10,000 rpm for 15 min. 
The pellets were resuspended in a minimal volume of 50 mM Tris-HCl 
@H 7.5) plus protease inhibitors (1 mM phenylmethyl-sulfonyltIuoride, 
1 &ml pepstatin A, 1 @ml antipain, 10 &nl aprotinin), snap frozen 
in liquid NZ and stored at -80°C. In some experiments, the myelin 
pellets were homogenized in 1.2 M sucrose, overlaid with steps of 0.75 
M, 0.55 M and 0.32 M sucrose in 50 mM Tris (pH 7.5) with 2 mM 
EGTA, and centrifuged at 28,000 rpm for 18 h. The floated myelin at 
the 0.75 MO.55 M interface was collected, centrifuged and stored as 
above. 
2.4. Assay for GTP-binding proteins 
Dishes of cells were placed on ice and washed once in 3 ml of cold 
PBS (pH 7.4) and twice in 3 ml SIEP buffer (250 mM sucrose, 3.0 mM 
imidazole, 0.5 mM EDTA, 1 mM phenyhnethylsulfonylfluoride, 1 ,@ 
ml pep&tin A and antipain (Sigma), lO,&nl aprotinin (Calbiochem), 
pH 7.4). Cells were harvested by scraping them into the small remaining 
volume of buffer left on the dish plus a scrape of residual material with 
another 50 ~1 SIEP. Cells were homogenized by 10 passes through a 25 
6/8 gauge needle affixed to a syringe, and centrifuged at 3,ooO rpm for 
10 min at 4°C in order to Pellet the nuclei and cellular debris. The 
supernatant fraction was centrifuged (Beckman TL-100) at 60,000 rpm 
for 30 min at 4°C. The resulting membrane pellet was resuspended in 
a small volume of STEP and stored at -80°C. Protein content was 
determined using a Lowry assay kit (Bio-Rad). 
Resolution and detection of low molecular weight GTP-binding pro- 
teins was carried out by two dimensional gel electrophoresis and 
[a-‘*P]GTP overlay blotting as previously described [23] using 5&100 
pg of cellular microsomal membrane fraction or myelin membrane total 
protein per gel. Immunoblotting of specific regions of the resulting 
nitrocellulose membranes was performed with the enhanced chemilu- 
minesence (ECL) Western blot kit (Amersham). Antisera to rab 3a and 
3a/b were obtained from R. Jahn (Yale University), rab 1 and rab 6 
from B. Goud (Pasteur Institute, Paris), rap 2 from J. de Gunzburg 
(INSERM U-248, Paris), ral A from R. Scheller (Stanford University, 
Stanford), rho A from A. Hall (Univ. College, London). 
3. Results 
3.1. Expression of small GTP-binding proteins as a 
function of oligodendrocyte development in culture 
Oligodendrocyte cultures at several stages of the devel- 
opmental ineage were harvested and analyzed for their 
expression of small GTP-binding proteins by two dimen- 
sional electrophoresis followed by [cl-32P]GTP-binding 
and autoradiography. The GTP-binding pattern (Fig. 2) 
changed from a relatively simple one in the early progen- 
itors (CGD3+’ progenitors, Fig. 1) to one significantly 
more complex in mature oligodendrocytes expressing 
L.A. Huber et al.lFEBS Letters 347 (1994) 273-278 
PDGF+bFGF bFGF R-mAb 
275 
Early 
Progenitor 
(GD3+) 
Late 
Progenitor 
(Pro-OL) 
Pr~gdtw-&oL 
(Pre-GalC) 
Immature OL 
(GalC+) 
Mature OL 
(MBP+) 
Fig. 1. Developmental lineage of oligodendrocytes. Developmental stages are identified by stage-specific panels of marker expression, some of which 
are shown in parentheses ( ee section 2, summarized more extensively in reference [ 11). Three stages at which progenitor lineage progression can be 
reversibly blocked by growth factors (PDGF and bFGF together, or bFGF alone) or antibody perturbation (R-mAb) are indicated by vertical arrows. 
later myelinogenic markers (‘Mature OLs’, Fig. 1). Pro- 
teins expressed by early progenitors were expressed 
throughout the lineage. The bottom panel of Fig. 2 
shows a diagrammatic representation of the pattern ex- 
hibited by mature oligodendrocytes, with each spot as- 
signed a name or letter designation (detailed below). 
Two proteins (spots J and M) were markedly up-regu- 
lated as the cells progressed from Early Progenitors to 
Late Progenitors (Fig. 2). This pattern remained similar 
through the ‘Progenitor-OL Interface’ and ‘Immature 
OL’ stages, although over-exposure of the films demon- 
strated the appearance of some new spots in the Imma- 
ture OL stage. As the cells matured further to the mature 
OL stage (Fig. 2, ‘More Mature OLs’) and began ex- 
pressing late differentiation makers such as proteolipid 
protein and myelin basic protein, spots J and M were 
further up-regulated. In addition at this stage, three 
prominent spots (spots I, H and K) were markedly up- 
regulated, and 2 8 more weakly labeled spots appeared. 
Therefore, the overall pattern observed demonstrates a
sequential up-regulation of additional small GTP-bind- 
ing proteins during the course of oligodendrocyte lineage 
progression. 
In contrast to oligodendrocytes, the pattern of GTP- 
binding proteins from extracts of cultures highly en- 
riched for astrocytes (Fig. 2, astrocytes) was relatively 
simple, containing about 16 spots. One of these spots 
(asterisk) may be specific for astrocytes. 
3.2. Identzjication of small GTP-binding proteins 
expressed by oligodendrocytes 
Some of the small GTP-binding proteins expressed by 
oligodendrocytes could be identified with varying de- 
grees of certainty by comparison to a GTP-binding pro- 
tein mobility map generated from an analysis of other 
cell types, especially MDCK cells and Baby Hamster 
Kidney cells [23,36] based on over-expression of cloned 
cDNAs and immuno-blotting, and/or immuno-blotting 
of material generated in this study (Fig. 2, bottom panel). 
The two spots labeled A and B are reproducible position- 
ing markers that are conserved among a number of dif- 
ferent cell types [23]; the molecular identity of these spots 
is currently unknown. 
Protein identifications presumed strictly on the basis 
of co-migration with previously identified proteins are 
indicated by parentheses in the bottom panel of Fig. 2. 
These include rab Sa,b,c, rab 7, rab 11, rab 22, rat, and 
rho D. Spots E and F had mobilities that were similar 
to rab 4 and rab 9, respectively, though due to the large 
number of spots in this area resolution and identification 
of these two proteins is difficult without immunostain- 
ing. Spots G, L, and N had mobilities previously ob- 
served in other cell types, but identification for these 
proteins is still lacking. A spot in the position expected 
for rab 8 was not observed. 
Those proteins identified by both mobility and im- 
munoblotting with available anti-sera, indicated in Fig. 
2 (bottom panel) with an asterisk, are rab 3, rap 2, ral 
A and rho. Spots I (an early developmentally regulated 
protein), K (a late developmentally regulated protein), 
and M migrate at the positions of rab la/lb, rab 10, and 
rab 17, respectively, but failed to immunoblot with anti- 
sera to these proteins (see section 4). The Golgi-specific 
GTP-binding protein rab 6 was demonstrated by im- 
munoblot to be present as a doublet, possessing a differ- 
ent mobility at a slightly higher p1 than had previously 
been observed for this protein in other cell types ([23], 
Fig. 2). 
A number of additional proteins (C, D, H, I, J, P, Q, 
R, S, T) did not correspond to previously observed ex- 
amples, and are therefore candidates for oligodendro- 
cyte/myelin-specific low molecular weight GTP-binding 
proteins. 
The pattern of GTP-binding proteins observed for my- 
elin isolated from postnatal day 15 rat brain was com- 
pared to that exhibited by mature oligodendrocytes in 
culture. A noticeable difference was the absence of rab 
6 in myelin, and the greater relative amount of rab 3 
(both confirmed by immunoblotting). Sequential im- 
munoblotting with antisera to rab 3a and 3aIb suggested 
that rab 3 in myelin was the 3a subtype. Rab 3a is a 
known component of regulated exocytic vesicles in syn- 
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drab 11) 
Fig. 2. Patterns of expression of small GTP-binding protein expression during development of oligodendrocytes, myelin and astrocytes. Two- 
dimensional gel electrophoresis (isoelectric focusing (IEF, PI-4-9), followed by SDS-PAGE) was followed by [c~*P]GTP overlay and autoradiogra- 
phy. The regions of the gels encompassing a molecular weight range of - 18-28 kDa are shown. Arrows indicate two prominent proteins (J and M) 
that are up-regulated at the Late Progenitor stage, and further at the More Mature OL stage. Arrowheads indicate three proteins (I, H, and K) in 
particular that are prominently up-regulated as cells enter the Mature OL stage. A small GTP-binding protein that may be novel to astrocytes is 
indicated with an asterisk. The continuous nature of the signal below postioning spots A and B in the myelin sample was uncharacteristic, and was 
resolved into discrete spots in other experiments. The bottom panel is a diagrammatic representation of the autoradiograph from an analysis of More 
Mature OLs in culture. The GTP-binding proteins have been labeled with specific names when warranted by identification by co-migration 
(parentheses) or immunoblotting (diamond), or both (asterisks). Other spots have been given arbitrary letter names pending further identification. 
The hatched symbols indicate GTP-binding proteins that were detected at all stages of oligodendrocyte differentiation; the solid symbols indicate 
GTP-binding proteins that were up-regulated uring oligodendrocyte lineage progression. 
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aptic nerve terminals and certain exocrine and endocrine 
cells that is believed to function in the fidelity of the 
regulated exocytic process [37]. Recent analyses indicate 
that rab3a expression is regulated in OLs and may con- 
stitute an exocytic system in developing OLs and myelin 
synthesis [38]. Experiments with myelin isolated from 
adult rat brain produced results similar to post-natal day 
15 myelin (data not shown). 
4. Discussion 
During development, OL progenitors mature from rel- 
atively simple cells into multi-processed cells producing 
and maintaining prodigious amounts of myelin mem- 
brane [l]. It is hypothesized that OLs must undergo sub- 
stantial changes in their molecular cytoarchitecture as 
they enter terminal differentiation in preparation for my- 
elin membrane biogenesis. Specific among these pro- 
posed changes are expected to be up-regulation of com- 
ponents (both general and cell type specific) of the ma- 
chinery governing vesicular membrane trafficking, in- 
cluding the expression of small GTP-binding proteins 
involved in the formation and delivery of vesicles bearing 
proteins and lipids destined for myehn membrane. As 
expected, the overall result demonstrates ubstantially 
increased complexity in the expression of small GTP- 
binding proteins as the cells prepare for and execute 
myelin biogenesis. 
Small GTP-binding proteins have been identified in 
brain [21,39,40] and in oligodendrocytes and myelin 
using one dimensional SDS-PAGE [41,42]. By adding a 
second dimension of characterization based on isoelec- 
tric point, and comparing the results with a substantial 
body of data obtained from other cell types, we have 
been able to extend such analyses. The overall GTP- 
binding pattern during oligodendrocyte development is 
a progression from a simple pattern to a more complex 
one as the cells enter terminal differentiation. GTP-bind- 
ing proteins that are present hroughout lineage progres- 
sion may participate in aspects of vesicular transport 
common to most or all eucaryotic cells. In this regard, 
rab 4,5,7 and 9 (different compartments of the endocytic 
pathway), rab 6 (Golgi-associated), rab 11 (secretory 
pathway), and rap 2 (cytoskeletal-associated) are present 
throughout OL development. The endocytic proteins 
were strongly represented in OLs and in myelin extracts, 
therefore the possibility of endocytosis in myelin must be 
entertained. The presence of multi-vesicular bodies in 
myelin has been previously observed [43], which may be 
structural evidence for this possibility. 
Most of the proteins that undergo developmental reg- 
ulation in OLs are unidentified, and it is hypothesized 
that these proteins participate in specialized sorting func- 
tions associated with a differentiated phenotype. Specifi- 
cally, two proteins (spots J and M) are up-regulated as 
the cells progress from early to later progenitors, and are 
further up-regulated as the cells enter terminal differenti- 
ation; three additional proteins (spots I, H and K) are 
strongly up-regulated only as the cells enter later stages 
of terminal differentiation; and a group of about 8 addi- 
tional proteins are also up-regulated late in terminal dif- 
ferentiation, but are less strongly labeled in the overlay 
assay. This group of unknown developmentally-regu- 
lated GTP-binding proteins may participate in pathways 
specifically associated with trafficking of differentiated 
OL products into the myelin membrane. One of the 
known proteins that demonstrates developmental regu- 
lation is rab 3a (see results). Though spots K and M 
migrated similarly to rab 17 and rab 10, technical diffi- 
culties with the ant&era precluded deiinitive identmca- 
tion of these two proteins. Rab 17 is localized to the 
basolateral plasma membrane and apical tubules [25]. 
Rab 8, involved in the specific transport of membrane 
proteins to the basolateral surface of kidney epithelial 
cells and to the dendritic membrane domains of hip- 
pocampal neurons [24], was notably undetectable. 
It is important to note that ‘purified’ myelin is a bio- 
chemical entity, based on a high lipid to protein ratio and 
thus on the ability to float myelin to a characteristic 
density on sucrose gradients. The possibility of contami- 
nation with other membranes, in particular axonal mem- 
branes, is always present. We have addressed this by 
including in our purification procedures a variety of 
techniques designed to minimize axonal contamination. 
These include, in addition to the traditional purification 
steps, homogenization and incubation in 10 mM EGTA 
[35] and floating the material to a 0.55 M sucrose step 
(1.06 g/cc). Even after extensive further purification, the 
pattern of GTP-binding proteins shown in Fig. 2 was 
retained, and we conclude that myelin has indeed a rich 
population of these proteins. This complexity of GTP- 
binding proteins in myelin, while perhaps surprising in 
its variety, is consistent with its recognized metabolic 
activity [44]. 
In summary, the present data demonstrate an exten- 
sive up-regulation in oligodendrocytes of a family of 
proteins intimately involved in vesicular transport. The 
developmentally regulated expression of these small 
GTP-binding proteins correlates well with changes in 
other parameters of myelinogenesis, including dramatic 
changes in morphology, and in the synthesis of myelin- 
specific lipids and proteins. The expression of several 
previously unrecognized proteins suggests that oligoden- 
drocytes may utilize cell-type specitlc GTP-binding pro- 
teins to effect this unique developmental program that 
culminates in the biogenesis, and maintenance, of the 
myelin membrane. 
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